识别5年内使用抗癫痫药物无法达到癫痫缓解的患者
研究基于SANAD数据集,采用多变量方法结合基线和随访数据预测癫痫患者5年内是否达到12个月无发作缓解。模型分类95%患者,其中预测未缓解者76%确实未缓解,外部验证准确率相似。结论认为该模型可在新临床信息出现时更新预测,辅助患者咨询和管理决策。
要点
- 模型可动态预测癫痫患者5年内未达12个月缓解的风险。
- 预测未缓解的阳性预测值为76%(95%CI 58.5%-88.2%)。
- 外部验证在2个英国独立数据集获得相似准确率。
核心结论
- 该多变量方法可在新临床信息出现时生成最新的未达癫痫缓解风险预测,可能有助于患者咨询和管理决策。
研究设计与样本
- 基于SANAD(Standard and New Antiepileptic Drug)研究的前瞻性数据集,应用近期开发的多变量方法,纳入基线协变量和随访数据作为预测变量。
主要发现
- 发作次数变化和治疗史是最具信息量的时间依赖预测因子,并与神经系统损伤史、癫痫类型、治疗开始年龄、性别及一级亲属癫痫史相关。
- 模型对95%的患者进行了分类;其中观察未达5年缓解者中95%被正确分类(95%CI 89.5%-100%),51%在3年内被识别、90%在4年随访内被识别。
- 观察达到5年缓解者中97%被正确分类(95%CI 93.3%-98.8%);预测未缓解者中76%确实未缓解(阳性预测值,95%CI 58.5%-88.2%)。
- 外部验证在2个英国独立数据集中达到相似准确率水平。
临床怎么用
- 原文结论指出该预测方法可在新临床信息出现时更新患者未达癫痫缓解的风险预测,可能有助于患者咨询和管理决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify people with epilepsy who will not achieve a 12-month seizure remission within 5 years of starting treatment. METHODS: The Standard and New Antiepileptic Drug (SANAD) study is the largest prospective study in patients with epilepsy to date. We applied a recently developed multivariable approach to the SANAD dataset that takes into account not only baseline covariates describing a patient's history before diagnosis but also follow-up data as predictor variables. RESULTS: Changes in number of seizures and treatment history were the most informative time-dependent predictors and were associated with history of neurologic insult, epilepsy type, age at start of treatment, sex, and having a first-degree relative with epilepsy. Our model classified 95% of patients. Of those classified, 95% of patients observed not to achieve remission at 5 years were correctly classified (95% confidence interval [CI] 89.5%-100%), with 51% identified by 3 years and 90% within 4 years of follow-up. Ninety-seven percent (95% CI 93.3%-98.8%) of patients observed to achieve a remission within 5 years were correctly classified. Of those predicted not to achieve remission, 76% (95% CI 58.5%-88.2%) truly did not achieve remission (positive predictive value). The predictive model achieved similar accuracy levels via external validation in 2 independent United Kingdom-based datasets. CONCLUSION: Our approach generates up-to-date predictions of the patient's risk of not achieving seizure remission whenever new clinical information becomes available that could influence patient counseling and management decisions.
引用
- Hughes DM, Bonnett LJ, Czanner G, et al. Identification of patients who will not achieve seizure remission within 5 years on AEDs. Neurology. 2018. PMID: 30389894. doi:10.1212/WNL.0000000000006564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。